IGEV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IGEV, covering 2010-09-02 to 2010-09-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma [Phase 2]